The 2.625% convertible notes are due 2027

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Lantheus Holdings, Inc. of $575 million aggregate principal amount of its 2.625% convertible senior notes due 2027, which included $75 million principal amount of notes pursuant to the exercise in full of the initial purchaser’s option to purchase additional notes. The notes are fully and unconditionally guaranteed by Lantheus Medical Imaging, Inc., a direct wholly owned subsidiary of Lantheus.

Lantheus is an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow serious medical conditions. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden.

The Davis Polk corporate team included partner Yasin Keshvargar and associates Dennis Chu and Carlos E. Romero. The equity derivatives team included partner Mark J. DiFiore and associate Gregory Edgar Marchesini. Partner Lucy W. Farr and associate Benjamin Helfgott provided tax advice. Partner David R. Bauer and associate Alison T. Chin provided intellectual property advice. All members of the Davis Polk team are based in the New York office.